Cargando…

Allosteric Nanobodies Reveal the Dynamic Range and Diverse Mechanisms of GPCR Activation

G-protein coupled receptors (GPCRs) modulate many physiological processes by transducing a variety of extracellular cues into intracellular responses. Ligand binding to an extracellular orthosteric pocket propagates conformational change to the receptor cytosolic region to promote binding and activa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Staus, Dean P, Strachan, Ryan T, Manglik, Aashish, Pani, Biswaranjan, Kahsai, Alem W, Kim, Tae Hun, Wingler, Laura M, Ahn, Seungkirl, Chatterjee, Arnab, Masoudi, Ali, Kruse, Andrew C, Pardon, Els, Steyaert, Jan, Weis, William I, Prosser, R. Scott, Kobilka, Brian K, Costa, Tommaso, Lefkowitz, Robert J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961583/ https://www.ncbi.nlm.nih.gov/pubmed/27409812 http://dx.doi.org/10.1038/nature18636

Ejemplares similares

Allosteric activation of proto-oncogene kinase Src by GPCR–beta-arrestin complexes
por: Pakharukova, Natalia, et al.
Publicado: (2021)

Unique Positive Cooperativity Between the β-Arrestin–Biased β-Blocker Carvedilol and a Small Molecule Positive Allosteric Modulator of the β2-Adrenergic Receptor
por: Pani, Biswaranjan, et al.
Publicado: (2021)

Conformationally Selective RNA Aptamers Allosterically Modulate the β(2)-Adrenoceptor
por: Kahsai, Alem W., et al.
Publicado: (2016)

The GPCR–β-arrestin complex allosterically activates C-Raf by binding its amino terminus
por: Zang, Yunxiang, et al.
Publicado: (2021)

Small-Molecule Positive Allosteric Modulators of the β(2)-Adrenoceptor Isolated from DNA-Encoded Libraries
por: Ahn, Seungkirl, et al.
Publicado: (2018)

Activation and allosteric modulation of a muscarinic acetylcholine receptor
por: Kruse, Andrew C., et al.
Publicado: (2013)

Allosteric modulator potentiates β(2)AR agonist–promoted bronchoprotection in asthma models
por: Ahn, Seungkirl, et al.
Publicado: (2023)

Adrenaline-activated structure of the β(2)-adrenoceptor stabilized by an engineered nanobody
por: Ring, Aaron M., et al.
Publicado: (2013)

Structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain
por: Wu, Arum, et al.
Publicado: (2023)

Allosteric coupling from G protein to the agonist binding pocket in GPCRs
por: DeVree, Brian T., et al.
Publicado: (2016)

Allosteric modulation of the GTPase activity of a bacterial LRRK2 homolog by conformation-specific Nanobodies
por: Leemans, Margaux, et al.
Publicado: (2020)

β-Arrestin–Biased Angiotensin II Receptor Agonists for COVID-19
por: Manglik, Aashish, et al.
Publicado: (2020)

An improved yeast surface display platform for the screening of nanobody immune libraries
por: Uchański, Tomasz, et al.
Publicado: (2019)

Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2
por: Singh, Ranjan K., et al.
Publicado: (2022)

Signal transduction at GPCRs: Allosteric activation of the ERK MAPK by β-arrestin
por: Kahsai, Alem W., et al.
Publicado: (2023)

Development of an antibody fragment that stabilizes GPCR/G-protein complexes
por: Maeda, Shoji, et al.
Publicado: (2018)

Structure of a nanobody-stabilized active state of the β(2) adrenoceptor
por: Rasmussen, Søren G. F., et al.
Publicado: (2011)

Applications of molecular replacement to G protein-coupled receptors
por: Kruse, Andrew C., et al.
Publicado: (2013)

Discrete GPCR-triggered endocytic modes enable β-arrestins to flexibly regulate cell signaling
por: Barsi-Rhyne, Benjamin, et al.
Publicado: (2022)

Improved GPCR ligands from nanobody tethering
por: Cheloha, Ross W., et al.
Publicado: (2020)

Crystal structure of a heterodimer of editosome interaction proteins in complex with two copies of a cross-reacting nanobody
por: Park, Young-Jun, et al.
Publicado: (2012)

Nanobody Mediated Crystallization of an Archeal Mechanosensitive Channel
por: Löw, Christian, et al.
Publicado: (2013)

Structural basis of inhibition of lipid-linked oligosaccharide flippase PglK by a conformational nanobody
por: Perez, Camilo, et al.
Publicado: (2017)

Structure of the δ-opioid receptor bound to naltrindole
por: Granier, Sébastien, et al.
Publicado: (2012)

Domain-interface dynamics of CFTR revealed by stabilizing nanobodies
por: Sigoillot, Maud, et al.
Publicado: (2019)

In vivo and in vitro characterizations of melibiose permease (MelB) conformation-dependent nanobodies reveal sugar-binding mechanisms
por: Katsube, Satoshi, et al.
Publicado: (2023)

Mapping inhibitory sites on the RNA polymerase of the 1918 pandemic influenza virus using nanobodies
por: Keown, Jeremy R., et al.
Publicado: (2022)

Structure of active β-arrestin1 bound to a G protein-coupled receptor phosphopeptide
por: Shukla, Arun K., et al.
Publicado: (2013)

Nanobody-enabled monitoring of kappa opioid receptor states
por: Che, Tao, et al.
Publicado: (2020)

Functional Consequences of GPCR Heterodimerization: GPCRs as Allosteric Modulators
por: Haack, Karla K.V., et al.
Publicado: (2011)

Crystal structure of the μ-opioid receptor bound to a morphinan antagonist
por: Manglik, Aashish, et al.
Publicado: (2012)

Allosteric Modulator Leads Hiding in Plain Site: Developing Peptide and Peptidomimetics as GPCR Allosteric Modulators
por: Olson, Keith M., et al.
Publicado: (2021)

Production, crystallization and X-ray diffraction analysis of two nanobodies against the Duffy binding-like (DBL) domain DBL6∊-FCR3 of the Plasmodium falciparum VAR2CSA protein. Corrigendum
por: Vuchelen, Anneleen, et al.
Publicado: (2013)

Allosteric interactions in the parathyroid hormone GPCR–arrestin complex formation
por: Clark, Lisa J., et al.
Publicado: (2020)

In Silico Study of Allosteric Communication Networks in GPCR Signaling Bias
por: Morales-Pastor, Adrian, et al.
Publicado: (2022)

Targeting G protein-coupled receptor signaling at the G protein level with a selective nanobody inhibitor
por: Gulati, Sahil, et al.
Publicado: (2018)

Nanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma Cells
por: De Groof, Timo W. M., et al.
Publicado: (2019)

GPCR Activation States Induced by Nanobodies and Mini-G Proteins Compared by NMR Spectroscopy
por: Rößler, Philip, et al.
Publicado: (2020)

Discovery of β2 Adrenergic Receptor Ligands Using Biosensor Fragment Screening of Tagged Wild-Type Receptor
por: Aristotelous, Tonia, et al.
Publicado: (2013)

An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology
por: J Gingell, Joseph, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_aaipm7av8uj15lgv1s4s69u7ng